Reddy Biotec Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 21 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
About Reddy Biotec
Reddy Biotec Limited (RBL) is a Public Limited Indian Non-Government Company incorporated in India on 04 September 2003 and has a history of 21 years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239DL2003PLC122095
-
Company No.
122095
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
04 Sep 2003
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Reddy Biotec?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Konda Reddy
|
Director | 04-Sep-2003 | Current |
|
Konda Reddy
|
Director | 04-Sep-2003 | Current |
|
Vishnu Konda
|
Director | 28-Mar-2018 | Current |
Financial Performance of Reddy Biotec.
Reddy Biotec Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reddy Biotec?
In 2016, Reddy Biotec had a promoter holding of 99.98% and a public holding of 0.02%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Reddy Seeds Private LimitedKonda Reddy and Konda Reddy are mutual person
-
Reddy Pharmaceuticals LimitedKonda Reddy and Vishnu Konda are mutual person
-
Reddy LimitedKonda Reddy, Konda Reddy and 1 more are mutual person
-
Reddy Life Sciences Private LimitedKonda Reddy and Konda Reddy are mutual person
-
Reddy Holdings Private LimitedKonda Reddy and Konda Reddy are mutual person
-
Reddy Dairy Private LimitedKonda Reddy and Konda Reddy are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Reddy Biotec?
Unlock and access historical data on people associated with Reddy Biotec, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reddy Biotec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reddy Biotec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
